S i s s i  V .  P h a m ,  P h a r m D M a n a g i n g  D i r e c t o r SPC provides outcomes consulting and research support customized uniquely for the client's needs. Sissi Pham has sixteen years of diverse experience in the pharmaceutical industry: Global and US drug development Reimbursement & formulary access Patient monitoring/adherence tools Promotional messages Health care systems/policy evaluation Communications/dissemination plan Strategic and business planning Health outcomes research US market support Market shaping/building strategy Product launch Database/observational studies Field training Staff and budget management Prior to starting her consulting firm, Sissi was the Global Health Outcomes Regional Director, North America at GlaxoSmithKline. She has extensive experience in designing and implementing health outcomes research strategies for global drug development and US market support in therapy areas such as, infectious diseases, gastrointestinal, neurology, oncology, respiratory, and urology. She has been directly involved in the launch of CombivirŪ and AdvairŪ. She has developed a reputation for strategic, innovative thinking and delivery orientation. Her contribution to the HIV community and GSK is the Aids Drug Assistance Program (ADAP) budget model that has been credited with securing annual federal and state funding for AIDS patients since 1996. She was invited to present the ADAP budget model to the Office of Management and Budget (OMB). Sissi represented GSK on the PhRMA Health Outcomes Committee, the intercompany Health Economics and Policy Ad Hoc Group, and Program on Health Outcomes at UNC School of Public Health. She served as the Institutional Council Chair for ISPOR, 2004-6. She continues to be active with PhRMA and ISPOR initiatives related to benefit-risk, health technology assessments and evidence based medicine. Sissi also serves as an Associate Clinical Professor at the University of Arizona's College of Pharmacy.